| Literature DB >> 23240045 |
Smriti Shringi1, Carrie Schmidt, Kaya Katherine, Kelly A Brayton, Dale D Hancock, Thomas E Besser.
Abstract
BACKGROUND: Shiga toxin (Stx) are cardinal virulence factors of enterohemorrhagic E. coli O157:H7 (EHEC O157). The gene content and genomic insertion sites of Stx-associated bacteriophages differentiate clinical genotypes of EHEC O157 (CG, typical of clinical isolates) from bovine-biased genotypes (BBG, rarely identified among clinical isolates). This project was designed to identify bacteriophage-mediated differences that may affect the virulence of CG and BBG.Entities:
Mesh:
Substances:
Year: 2012 PMID: 23240045 PMCID: PMC3519850 DOI: 10.1371/journal.pone.0051572
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Summary of genetic differences among three clinical genotypes (CG) and four bovine-biased genotypes (BBG) of EHEC O157 identified using optical mapping technology.
| Total number of genetic rearrangements | |||||||
| Strain | SBI Genotype | Genome size (bp) | BamHI fragments (No.) | Insertions | Deletions | RFLP | Others |
| E2325 | CG-1 (AY2) | 5,407,641 | 478 | 2 | 6 | 24 | 1 Inv, 3 Sub |
| E5252 | CG-3 (WY12) | 5,376,952 | 488 | 0 | 7 | 7 | 1 Sub |
| E3046 | CG-3 (WY12) | 5,486,716 | 540 | 1 | 0 | 16 | 1 Inv, 1 Sub |
| E5880 | BBG-5 (SY2c) | 5,426,915 | 532 | 2 | 7 | 12 | 2 Inv, 5 Sub |
| E3855 | BBG-5 (SY2c) | 5,390,209 | 500 | 5 | 10 | 16 | 3 Sub |
| E2309 | BBG-6 (ASY12c) | 5,504,252 | 518 | 3 | 6 | 11 | 1 Inv, 1 Tnv, 3 Sub |
| E6996 | BBG-6 (ASY12c) | 5,583,835 | 551 | 4 | 5 | 18 | 4 Sub |
Modified SBI genotype for each isolate is indicated in parenthesis. This shows the concatenation of presence of specific bacteriophage at argW, sbcB, wrbA or yehV locations designated by uppercase first letter of each insertion site (A, S, W or Y,) followed by the presence of stx1, stx2a or stx2c denoted by 1,2 or 2c.
Genome sizes predicted on the basis of optical maps of each strain.
Number of genetic rearrangements in comparison with strain Sakai (CG-3). Insertions = presence of additional restriction fragments; deletions = loss of RE fragments; RFLPs (restriction fragment length polymorphisms) = altered sizes and/or numbers of RE fragments; inversions (Inv) = RE fragments in reversed order; substitutions (Sub) = altered RE fragments; transversion (Tnv) = RE fragments in reversed order and in a different location.
Oligonucleotide primers and amplified PCR products in the study.
| Primer | Dye | Oligonucleotide sequences (5′-3′) | Target | Amplicon (bp) | Reference |
| 2851-80 | PET |
| Phage- | 914 |
|
|
| None |
| This study | ||
|
| VIC |
| Phage- | 730 | This study |
| 2851-82 | None |
|
| ||
|
| VIC |
|
| 406 | This study |
|
| None |
| This study | ||
| F | 6FAM |
| Phage- | 824 |
|
| B | None |
|
| ||
| A | PET |
| Phage- | 702 |
|
| E | None |
|
| ||
| A | PET |
| Phage- | 295 |
|
| E3 | None |
| This study | ||
| A | PET |
|
| 340 |
|
| B | None |
|
| ||
| C | 6FAM |
| Phage- | 592 |
|
| G | None |
|
| ||
| H | PET |
| Phage- | 506/537 |
|
| D | None |
|
| ||
| C | 6FAM |
|
| 314 |
|
| D | None |
|
| ||
|
| VIC |
| Phage- | 583 | This study |
|
| None |
| This study | ||
|
| 6FAM |
| Phage- | 462 | This study |
|
| None |
| This study | ||
|
| VIC |
|
| 216 | This study |
|
| None |
| This study | ||
| Stx1-2 | VIC |
| Stx1 | 475 |
|
| Stx1-1 | None |
|
| ||
| stx2-1072F | NED |
| Stx2a -specific | 126 |
|
| stx2-1197R | None |
|
| ||
| stx2c-F858 | NED |
| Stx2c -specific | 243 | This study |
| stx2c-R1100 | None |
|
|
Selected BBG polymorphisms in comparison to reference strain Sakai (CG-3).
| Sakai strain | |||||||
| Start Location (bp) | End Location (bp) | Fragment | Features | BBG strains | Polymorphism | Size (bp) | Stx-associated bacteriophage |
| 2,740,136 | 2,803,536 | 334–335 | SpLE2 ( | 1,2,3,4 | Insertion | ∼60,000 | Stx2c |
| 3,172,859 | 3,198,717 | 377–380 | Sp16 ( | 3 | Insertion | 48,365 | Stx2a |
| 3,198,717 | 3,219,331 | 381–382 | SP16 ( | 4 | Insertion | 58,185 | Stx2a |
| 1,246,750 | 1,310,488 | 142–151 | Sp5 | 1,2,3,4 | Deletion | 63,738 | Stx2a |
| 2,912,120 | 2,943,884 | 347–349 | Sp15 | 1 | RFLP | 3,718 | Stx1 |
| 2,912,120 | 2,943,884 | 347–349 | Sp15 | 2 | Substitution | 13,840 | Stx1 |
Sakai strain (CG-3) chromosomal location, in silico BamHI fragments, and features present in the polymorphic region.
Genes cited are known Stx-associated bacteriophage insertion sites. In Sakai, Sp5 is the Stx2-associated bacteriophage inserted in wrbA and Sp15 is the Stx1-associated bacteriophage inserted in yehV; Sp = Sakai prophage; SpLE = Sakai prophage like elements.
BBG isolate(s) in which the polymorphism was detected; 1: E5880; 2: E3855; 3: E2039; 4: E6996.
Stx-associated bacteriophage potentially involved in polymorphism based on optical maps.
SBI Genotyping on human and bovine isolates of EHEC O157.
| SBI Genotype Coding | Bovine (%) | Human (%) | Total (%) | SBI Genogroup | P-value | Former SBI genotype designation (%) |
| WY12 | 92 (40.5) | 97 (50.5) | 189 (45.1) | CG | 0.048 | 3 (91), 7 (6.4), 18 (2.1), 22 (0.5) |
| AY2 | 11 (4.8) | 47 (24.5) | 58 (13.8) | CG | <0.0001 | 1 (96.6), 19 (3.5) |
| SY2c | 45 (19.8) | 2 (1.0) | 47 (11.2) | BBG | <0.0001 | 5 (87.2), 1 (10.6), 19 (2.1) |
| ASY12c | 38 (16.7) | 8 (4.2) | 46 (11.0) | BBG | <0.0001 | 6 (100) |
| ASY22c | 5 (2.2) | 15 (7.8) | 20 (4.8) | CG | 0.01 | 1 (85), 5 (15) |
| SY12c | 14 (6.2) | 0 (0.0) | 14 (3.3) | BBG | 0.0004 | 6 (92.9), 16 (7.1) |
| ASY2 | 1 (0.4) | 12 (6.3) | 13 (3.1) | CG | 0.0005 | 1 (100) |
| W2 | 3 (1.3) | 8 (4.2) | 11 (2.6) | Unclassified | 0.12 | 4 (100) |
| WY2 | 4 (1.8) | 0 (0.0) | 4 (1.0) | Unclassified | N/A | 2 (100) |
| Y | 4 (1.8) | 0 (0.0) | 4 (1.0) | Unclassified | N/A | 17 (75), 10 (25) |
| ASY2c | 2 (0.9) | 0 (0.0) | 2 (0.5) | Unclassified | N/A | 5 (100) |
| AWY12 | 1 (0.4) | 1 (0.5) | 2(0.5) | Unclassified | N/A | 3, 18 |
| AY | 1 (0.4) | 0 (0.0) | 1 (0.2) | Unclassified | N/A | 10 (100) |
| Y1 | 0 (0.0) | 1 (0.5) | 1 (0.2) | Unclassified | N/A | 8 (100) |
| ASY1 | 1 (0.4) | 0 (0.0) | 1 (0.2) | Unclassified | N/A | 13 (100) |
| AY1 | 1 (0.4) | 0 (0.0) | 1 (0.2) | Unclassified | N/A | 13 (100) |
| WY1 | 1 (0.4) | 0 (0.0) | 1 (0.2) | Unclassified | N/A | 22 (100) |
| SWY2c | 1 (0.4) | 0 (0.0) | 1 (0.2) | Unclassified | N/A | 12 (100) |
| 0 (0.0) | 1 (0.5) | 1 (0.2) | Unclassified | N/A | 9 (100) | |
| SY122c | 1 (0.4) | 0 (0.0) | 1 (0.2) | Unclassified | N/A | 6 (100) |
| AWY2 | 1 (0.4) | 0 (0.0) | 1 (0.2) | Unclassified | N/A | 2 (100) |
| Total | 227 | 192 | 419 |
Concatenation of presence of specific bacteriophage at argW, sbcB, wrbA or yehV locations designated by uppercase first letter of each insertion site (A, S, W or Y,) followed by the presence of stx1, stx2a or stx2c denoted by 1,2 or 2c.
The SBI Genotypes that are significantly over-represented among cattle isolates as compared to human isolates are referred as bovine-biased genotypes (BBG); the SBI Genotypes that show significantly over-representation/similar-representation among human isolates as compared to cattle isolates are referred as clinical genotypes (CG); the SBI genotypes that could not be evaluated for a bovine association due to small numbers (1–4 isolates) are designated “unclassified” genotypes in this manuscript (Fisher’s exact test P≤0.05).
Percent of isolates belonging to most common previously defined SBI genotype [5], [10], [14].
Consistency of type of Stx-associated bacteriophage and stx in SBI genotypes in clinical and bovine strains.
| SBI genotypes | ||||||
| Stx-associated bacteriophage | Insertion site | Origin | CG | BBG | Unclassified | Total |
| Stx2a |
| Bovine | 92 (92) | 0 (0) | 11 (9) | 103 (101) |
| Human | 97 (97) | 0 (0) | 9 (9) | 106 (106) | ||
|
| Bovine | 17 (17) | 38 (0) | 7 (2) | 62 (19) | |
| Human | 74 (74) | 8 (0) | 1 (1) | 83 (75) | ||
| Stx2c |
| Bovine | 6 (5) | 97 (97) | 5 (4) | 108 (106) |
| Human | 27 (15) | 10 (10) | 0 (0) | 37 (25) | ||
| Stx1 |
| Bovine | 109 (92) | 97 (52) | 18 (5) | 224 (149) |
| Human | 171 (97) | 10 (8) | 2 (2) | 183 (107) | ||
| Strains in study | Bovine | 110 | 97 | 20 | 227 | |
| Human | 171 | 10 | 11 | 192 | ||
Numbers of isolates with the corresponding Stx-associated bacteriophage sequences in the insertion site. Numbers in parentheses indicate the isolate also positive for the expected stx. Association of the Stx-associated bacteriophage and stx2 gene variant with the BBG and CG strains was analyzed using the Fisher’s exact test (P≤0.05).
Two strains of AWY12 and single strain of AWY2 had Stx2-associated bacteriophages inserted into both argW and wrbA, and our data cannot determine whether stx2a is carried by one or both of these bacteriophages.
Stx-associated bacteriophage differences among SBI genotypes identified in earlier studies [5], [10].
Stx-associated bacteriophage differences among SBI genotypes identified in this study.